Free CME from PeerView


Urology CME

Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Revolutionizing Solid Tumor Treatment, Unleashing the Potential of Antibody–Drug Conjugates: How to Make the Most of the Latest Clinical Evidence to Enhance Patient Care
Paolo Tarantino, MD
November 14, 2023
Credits: 1.0 CME / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Can We Improve Management of Overactive Bladder in Long-Term Care? Examining the Role of Beta-3 Adrenergic Agonists
Benjamin M. Brucker, MD
June 13, 2023
Credits: 1.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Endometrial Cancer Care in the Age of Immunotherapy: Translating Clinical Evidence Into Meaningful Improvements in Patient Outcomes Across the Disease Continuum
David M. O'Malley, MD
June 04, 2023
Credits: 1.5 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the Disease Spectrum
Sumanta Kumar Pal, MD, FASCO
June 03, 2023
Credits: 1.25 CME / NCPD / ILNA / IPCE
PVI, PeerView Institute for Medical Education
Meeting Patient Needs Through Optimal Nursing Strategies in Personalized Bladder Cancer Care
Brenda Martone, MSN, ANP-BC, AOCNP
April 29, 2023
Credits: 1.5 CME / NCPD / ILNA / IPCE
PVI, PeerView Institute for Medical Education
Expert Nursing Insights on Personalized Care for Gynecologic Cancers: Educating and Supporting Patients on the Latest Therapeutic Approaches
Kimberly Halla, MSN, FNP-C
April 26, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Modern Urology Practice
Matthew D. Galsky, MD / Neal D. Shore, MD, FACS
April 11, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment
Janis Taube, MD, MSc
March 02, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Expanding Use of Hormonal Therapeutic Strategies in Prostate Cancer: Clinical Evidence and Practical Considerations for Individualized, Patient-Centered Care
Matthew R. Smith, MD, PhD
February 18, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Breaking New Ground in RCC Management: Expert Guidance on Leveraging Therapeutic Strategies
Sumanta Kumar Pal, MD, FASCO
February 17, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Fresh Perspectives on Moving Toward Personalized Care for Bladder Cancer: Tips, Tools, and Strategies for Leveraging the Latest Advancements Across the Disease Spectrum
Matthew I. Milowsky, MD, FASCO
February 17, 2023
Credits: 1.0 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
New Horizons for Advanced Endometrial Cancer Treatment: Utilizing Innovative Immunotherapies and Other Novel Approaches
Shannon N. Westin, MD, MPH
February 07, 2023
PVI, PeerView Institute for Medical Education
Case by Case: Maximizing Personalized Approaches to Prostate Cancer
Rana R. McKay, MD / Alicia K. Morgans, MD, MPH
November 30, 2022
PVI, PeerView Institute for Medical Education
Personalizing Bladder Cancer Care in the Modern Therapeutic Era: One Size No Longer Fits All
Petros Grivas, MD, PhD
November 30, 2022
PVI, PeerView Institute for Medical Education
Getting to the Heart of Personalized ADT for Advanced Prostate Cancer: Are You Able to Leverage New Data and Therapy Options to Maximize Cardiovascular Safety and Treatment-Related Outcomes?
Daniel J. George, MD
November 15, 2022
PVI, PeerView Institute for Medical Education
RCC Clinical Consults: Making Difficult Treatment Decisions at the Intersection of the Data and the Real World
Sumanta Kumar Pal, MD, FASCO
November 04, 2022
Medical Learning Institute, Inc.
Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient Care
Alicia K. Morgans, MD, MPH
October 31, 2022
PVI, PeerView Institute for Medical Education
Clinical Conundrums in Pretreated Metastatic Urothelial Carcinoma: Improving Patient Outcomes With Novel Antibody-Drug Conjugates
Scott T. Tagawa, MD, MS, FACP
October 27, 2022
Penn State College of Medicine
Controlling the Urgency Emergency, Restoring QOL: Safe and Effective Management of Overactive Bladder
David Staskin, MD
September 09, 2022
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Penn State College of Medicine
Transforming Bladder Cancer Treatment: Essential Guidance for Urologists on Therapeutic Selection, Safety, and Sequencing Along the Disease Continuum
Ashish M. Kamat, MD, MBBS
July 08, 2022
Medical Learning Institute, Inc.
Realizing the Potential of Novel Treatment Intensification Strategies for Metastatic Castration-Sensitive Prostate Cancer: The Experts’ Take on Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, Patient-Centered Care
Matthew R. Smith, MD, PhD
June 06, 2022
PVI, PeerView Institute for Medical Education
Refining RCC Management Across the Disease Continuum: An Expert Clinical Consult on Leveraging New Evidence and Novel Therapeutic Strategies to Personalize Patient Care
Toni K. Choueiri, MD
June 04, 2022
Medical Learning Institute, Inc.
Multidisciplinary Guidance on Translating the Latest Therapeutic Advances Into Patient Care for Early to Advanced Bladder Cancer: Clinical Consults and Cases From the Community
Ashish M. Kamat, MD, MBBS
May 15, 2022
PVI, PeerView Institute for Medical Education
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interprofessional Insights on Optimizing Outcomes With Novel Targeted and Immune-Based Therapies
Nancy P. Moldawer, RN, MSN
May 01, 2022
Medical Learning Institute, Inc.
Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
Robert Dreicer, MD, MS, MACP, FASCO
February 19, 2022
Medical Learning Institute, Inc.
Carrying Through in Advanced/Metastatic Urothelial Carcinoma: Expert Perspectives on Recent Practice‐Changing Data and the Practicalities of Individualizing and Continuing Care With Novel Immunotherapy Maintenance Strategies
Petros Grivas, MD, PhD
December 29, 2021
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
Robert Dreicer, MD, MS, MACP, FASCO / Pedro C. Barata, MD, MSc
December 01, 2021
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
Petros Grivas, MD, PhD
December 01, 2021

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView